PathAI

News

Roche buys AI-powered diagnostics player PathAI

Roche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn.

News

FDA backs first AI tool for use in trials, targeting MASH

The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with MASH to help measure disease activity.

News

EMA panel endorses AI for MASH clinical trials

PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.

News

Roche, PathAI team up on AI companion diagnostics

Roche has turned to artificial intelligence specialist PathAI to accelerate development of digital pathology technologies that can be used to match patients with drug treatments and s

Roche buys AI-powered diagnostics player PathAI

FDA backs first AI tool for use in trials, targeting MASH

EMA panel endorses AI for MASH clinical trials

Roche, PathAI team up on AI companion diagnostics

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

PathAI

Editor's Picks